华海药业注射用尼可地尔获批

Core Viewpoint - Huahai Pharmaceutical has received the drug registration certificate for injectable Nicorandil from the National Medical Products Administration, which enhances its product line and market competitiveness [1] Group 1 - Huahai Pharmaceutical announced the approval of injectable Nicorandil on November 17 [1] - The approval allows the product to be considered as having passed the consistency evaluation under the relevant national policies [1] - This new product approval is expected to enrich the company's product offerings [1]